Invitrogen™ ELISA Kit for Human CEA

Ref.: BL-RE-093218Manufacturer ref.: EHCEAX10 10 x 96 tests
€4,815.00 excl. VAT

CEA is synthesized in the fetus intestine during development and is again expressed in higher amounts in intestinal carcinomas and several other tumours. CEA is a member of the supergene family of the...

Accession number
P06731
Dose range
0.343 to 250 ng/ml
Sensitivity of the dosage
200 pg/ml
Conjugate
Biotin
Product type
ELISA
Brand
Invitrogen

CEA is synthesized in the fetus intestine during development and is again expressed in higher amounts in intestinal carcinomas and several other tumours. CEA is a member of the supergene family of the...

CEA is synthesized in the fetus intestine during development and is again expressed in higher amounts in intestinal carcinomas and several other tumours. CEA is a member of the family of immunoglobulin supergens, carcinoembryonic antigens, and consists of a single domain N and six domains of constant-type immunoglobulin A (A1, A2, A3) and B (B1, B2, B3). The ACE antibodies are useful in identifying the origin of the various metastatic adenocarcinomas and distinguishing between pulmonary adenocarcinomas (60-70% are CEA+) and pleural mesotheliomas (rarely or weakly CEA+). CEA is part of the large glycoprotein family, a tumour marker useful for adenocarcinoma, and found in the epithelium adenocarcinomas of the digestive system derived from lhe endoderma and the colon of the foetus. Two subgroups of the CEA family, CEA cell adhesion molecules and pregnancy-specific glycoproteins, are located in a 1.2 Mb group on the long arm of chromosome 19. Eleven pseudogenes from the CEA cell adhesion molecules subgroup are also present in the group. CEA was initially described in the liver bile canals as biliary glycoprotein. Subsequently, it was shown that CEA is a cell adhesion molecule detected on leukocytes, l'épithelium, and l'endothelium. Several transcription variants coding different isoforms were recorded, but the full length nature of all variants was not defined.

Sensitivity

Sensitivity of the dosage: 200 pg/ml.

Measurement range

Dose range: 0.343 to 250 ng/ml.

Duration of dosing

Total duration of dosing: 4 h 45 min.

Reproducibility

Coefficient of intradose variation < 10%, interdose < 12%.

Target

Target: CD66e (CEACAM5).

Technical specifications

General
BrandInvitrogen
Supplier ref. (Fisher Scientific)17707903
Specifications
Accession numberP06731
Dose range0.343 to 250 ng/ml
Sensitivity of the dosage200 pg/ml
ConjugateBiotin
Product typeELISA
Type of samplePlasma, Serum, Surnatant
For use with (equipment)Colorimetric microplate reader
Genetic identification (Enter)1048
Gene symbol(s)Ceacam5
Coefficient of inter-dose variation< 12%
Coefficient of intra-dose variation< 10%
Contents of kits96-well pre-coated plate, standard, dosing diluent concentrate, biotinylated detection antibody, SAV-HRP, washing pad, chromogen, stop solution, adhesive plate lids
Marker or dyeHRP
Quantity10 x 96 tests
Regulatory statusRUO
TargetCD66e (CEACAM5)
Test time1 h 20 min
Physical characteristics
Volume of samplePlasma, 50 μl-Serum, 50 μl-Surnatant, 100 μl
Storage and shipping
Storage conditions2°C to 8°C
Total duration of dosing4 h 45 min

Origin and customs

Manufacturer ref.EHCEAX10
Country of originUnited States
HS customs code3002 12 00 00
A question or a specific configuration?
Contact us for a quote.